Resistance to broad spectrum β lactams, mediated by extended spectrum beta lactamase (ESβL) is an increasing problem worldwide. Production of these enzymes in clinical infections can result in treatment failure if one of the second or third generation cephalosporins is used. This study investigates the incidence of ESBL among E. coli and K. pneumoniae which were isolated from tuberculosis patients with secondary opportunistic bacterial infection attending Aminu Kano Teaching Hospital (AKTH), Kano and Infectious Disease Hospital (IDH), Kano. A total of 37 E. coli and 33 K. pneumoniae obtained from their sputum were screened for ESBL production by Double disk synergy test method (DDST). Prevalence of 37.3% (14/37) and 36.4% (12/33) was recorded for Escherichia coli and Klebsiella pneumoniae respectively. Furthermore, a slight high prevalence of 39.4% (13/33) was recorded with the female tuberculosis patients when compared with their male counterpart 35.1% (13/37). Escherichia coli harboring ESBL were more encountered among the elderly patients aged 31-50 (13/51 or 25.5%) when compared with K. pneumoniae with (9/51 or 17.6%). The study shows alarming rise in ESBL production among Klebsiella pneumoniae and Escherichia coli among immunocompromised patients raising fear of possible emergence of multiple drug resistant bacteria that will be hard to treat. Thereby early detection of ESBL in these patients is recommended to curb the spread,
INTRODUCTION
The production of Beta-lactamase is an important mechanism of resistance to Beta-lactam antibiotics among gram negative bacteria (Coudron, 1997) . Extended-spectrum-beta-lactamases (ESBLs) are plasmid-mediated beta-lactamase of predominantly Bush class A, so far described only in gram negative bacilli (Emery and Weymouth, 1997) . ExtendedSpectrum-Beta-Lactamases are capable of efficiently hydrolyzing penicillin, narrow spectrum cephalosporins (cefotaxime, ceftazidine) and monobactams (aztreonam). Beta-Lactamase, inhibitors (clavulanic acid, sulbactam and tazobactam) generally inhibit ESBLs-producing strain (Naumoski and Paizkill, 1996) . Mostly ESBLs are mutant of TEM-1, TEM-2 and SHV-1, to date none has been described that is able to hydrolyze cephamycin or carbapenems (imipenem, meropenem) (Emery and Weymouth, 1997) . In addition, resistance to the extended spectrum cephalosporin has also arisen in Klebsiella pneumoniae and Escherichia coli (Spanu et al., 2002) .
Extended-Spectrum-Beta-Lactamase antibiotics such as third generation cephalosporin (3GC) form the major component of the empiric antibacterial chemotherapy in most clinical set ups and especially in tertiary care centers (Chaudary and Aggarwal, 2004) . Extensive use of third generation cephalosporins has contributed to the evolution of ESBL producing strains in bacteria (Chaudary and Aggarwal, 2004) . ExtendedSpectrum-Beta-Lactamase also occurs predominantly in other organisms including Salmonella spp., Pseudomonas aeruginosa and other Enterobacteriaceae (Spanu et al., 2002) .
The ESBLs are frequently plasmid encoded (Phillippon et al., 2002) . Plasmid responsible for ESBL production frequently carries gene encoding resistance to other drug classes (for example, amino glycoside) (Phillipon et al., 2002) . Therefore, antibiotic options in the treatment of ESBL producing organisms are extremely limited (Emery and Weymouth, 1997) . ESBL producing organism may appear susceptible to some extendedspectrum cephalosporins in vitro (Naumorski, and Paizkill 1996) . However, treatment with such antibiotics has been associated with high failure rate (Bradford, 2001 ).
Gram negative Enterobacteriaceae expressing ESBLs
are among the most multidrug-resistant pathogens in hospitals and are spreading worldwide. Infections caused by ESBL-producing organisms have resulted in poor prognosis, prolonged hospital stay and greater hospital expenses (Lautenbach et al., 2001 and Paterson et al., 2004) . Physical contact is the most likely mode of transmission.
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The gastrointestinal tract of colonized or infected patients is the most frequent reservoir (Paterson et al., 2004) . Several studies (Paterson et al., 2004) indicate that transient carriage of bacterial on the hands of healthcare workers (HCWs) may lead to transmission to patients. Tuberculosis (TB) is a common and often deadly infectious disease caused by various strains of Mycobacteria, usually Mycobacterium tuberculosis in human (Jasmer and Nahid, 2002) . Tuberculosis usually attacks the lung but can also affect other parts of the body. It is spread through the air when people who have the disease cough, sneeze or spit (Southwick, 2007) . The multi resistant phenotype emerges with sequential acquisition of mutations in several loci of separate gene (WHO, 2010 and Southwick, 2007) . Knowledge of this mechanism of resistance permits the development of techniques for the early detection of resistance strains, thereby making proper control possible (Southwick, 2007) . It has been found that tuberculosis patients whose immune system is compromised prone to many secondary bacterial infections. Some of the bacterial capable of causing such infections were found to be resistance to many antibiotics such as cefazolin, ceftazidine, imipenem, carbenicillin by producing enzymes such as extended-spectrum-beta-lactamases (ESBLs). Such isolates may cause serious opportunistic infections especially in tuberculosis patients.
Resistance to such enzymes in clinical isolate has lead to little or no treatment option which consequently leads to death. Therefore this study aimed at determining the occurrence of ESBL producers among E. coli and K. pneumoniae which often cause secondary bacterial infections in Tuberculosis patients and detect if transfer of resistant genes are possible between these bacteria of different genera. was placed at the center of the inoculated MHA. Ceftazidime (30ug, Oxoid , England) and Cefpodoxime (10ug, Oxoid , England) were placed 15mm center to center from the Amoxycillin/clavulanic acid discs. The plates were incubated at 37 o C for 24 hours. After incubation, enhancement of zone of inhibition of either or both the Ceftazidime and Cefpodoxime discs towards the Amoxycillin/Clavulanic acid discs is indicative of ESBL production. The enhancement is due to inhibition of ESBL by clavulanic acid and subsequent action of the extended spectrum cephalosporins.
MATERIALS AND METHOD Clinical Isolates

Transconjugation Test
The method adopted by Iroha et al., (2010) was used. One ESBL producing isolates each of E. coli and K. pneumoniae were selected for bacterial conjugation. The ESBL producing E. coli (donor) was transconjugated with 3 none ESBL producing K. Pneumoniae (recepient), while ESBL producing K. pneumoniae (donor) was transconjugated with 3 none ESBL E. coli (recepient). The recipient and the donor strains were grown separately in 5ml of a double strength Nutrient broth (Oxoid, England), incubated at 37 0 C for 24 hours. The cultures of donor and recipient were mixed at a ratio of 1:10 (donor: recepient) and incubated at 37 0 C for 3 hours. Samples of the mixture were inoculated on a differential media MacConkey (Hi-media, India) and incubated at 37 0 C for 24 hours. The colonial appearances of the mixed colonies of both E. coli and K. pneumoniae were carefully studied and the isolates were subjected to biochemical tests in accordance with the method described by Cheesbrough, 2002 for identification. The transconjugants were later screened for ESBL.
RESULTS AND DISCUSSION
The overall prevalence of ESBL among tuberculosis patient is 37.1% (Table 1) . Escherichia coli recorded a prevalence of 37.8% followed by Klebsiella pneumoniae with 36.4% prevalence (Table 1) The nearly similar prevalence of 36.4% and 37.8% for K. pneumoniae and E. coli in this study also agreed with the findinds of Babypadmini and Appalaraju (2004) , who reported 40 and 41% ESBL positivity among K. pneumoniae and E. coli, respectively, but a more higher prevalence of 86% for Klebsiella pneumoniae and 40% for Escherichia coli in tuberculosis patients was reported by Jayapradha et al., in 2007. The present study revealed a slightly higher recovery of ESBL producers in males (E. coli, 38.9%; K. pneumoniae, 40%) than in females (E. coli, 36.8%; K. pneumoniae 33.3%). This was incomparable with other findings which reported a higher preponderance in females. The age wise distribution of the ESBL producers among the patients showed the highest prevalence among the 51-above years age group (33.3%). This is in accordance with findings of Kiratisin et al., (2008) . This may be because of the increased hospitalization of the patients with ages around 60 years in the medical and surgical units due to their weaker immunity. The knowledge of the resistance pattern of the bacterial strains in tuberculosis patients will help in guiding an appropriate and judicious antibiotic use putting into consideration their already compromised immune status. There is a possibility that a restricted use of antibiotics can lead to the withdrawal of the selective pressure and that the resistant bacteria will no longer have a survival advantage in such settings. This study also revealed transfer of resistant genes between ESBL producing E. coli and K. pneumoniae to non ESBL producing K. pneumoniae and E. coli respectively (Table 4) . Shi et al., (2009) also reported similar transfer between K. pneumoniae and E. coli. High rate of this transfer occurred between E. coli and K. pneumoniae (66.7%) than vice verca (33.3%). This indicated that plasmid carrying ESBL gene in one bacteria can spread rapidly to members of the same species or organisms of different genera in the same or different individual. Furthermore, the study also revealed the possibility of transfer of antibiotic resistance genes between pathogens and normal flora of the upper respiratory tract which under immunesuppressed condition can cause infections that may be difficult to treat. 
